ServiceUpdated on 18 September 2024
Global Cell and Gene Therapy CDMO
About
Catalent Cell & Gene Therapy is an industry-leading Contract Development and Manufacturing Organization (CDMO) for advanced therapeutics. Our comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including CAR-T, TCR, TILs, NKs, iPSCs, and MSCs. With deep expertise in viral vector development, scale-up and manufacturing for gene therapies, Catalent is a full-service CDMO for plasmid DNA, adeno-associated viral (AAV), lentiviral and other viral vectors, oncolytic viruses, and live virus vaccines. An experienced and innovative partner, Catalent Cell & Gene Therapy has a global network of dedicated, small- and large-scale clinical and commercial manufacturing facilities, including an FDA-licensed viral vector facility, and fill/finish capabilities located in both the U.S. and Europe.
Type
- Development
- Manufacturing
Similar opportunities
Expertise
Viral vector development for gene delivery/gene therapy
Benjamin DAMIEN
CEO at SAGITTA BIOTECH
Liège, Liège, Belgium
Service
Formulation development & production services (bottle mixer)
Jeroen Mangelschots
Business Development Executive at White Raven
Liége, Belgium
Service
Aseptic filling services (Robotic Gloveless Isolator)
Jeroen Mangelschots
Business Development Executive at White Raven
Liége, Belgium